Blocking stomach blood flow to fight obesity: a new approach?

NCT ID NCT04207424

Terminated Disease control Sponsor: IHU Strasbourg Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study planned to test a procedure called bariatric embolization for people with morbid obesity who cannot have standard weight-loss surgery. The procedure involves injecting tiny particles into blood vessels near the stomach to reduce blood flow, which may lower hunger hormones and help with weight loss. However, the study was withdrawn before any participants were enrolled, so its safety and effectiveness remain unknown.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Embolization of the gastro-epiploic arcade using polyvinyl-alcohol microparticles
What this could lead to: If it worked, this procedure could offer a less invasive option for weight loss in people who cannot have bariatric surgery.
What could go wrong: The study was withdrawn before enrolling anyone, so no results are available. The procedure carries risks like allergic reaction to contrast dye and potential complications from blocking blood vessels.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MORBID OBESITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

metabolic syndrome X morbid obesity Obesity

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MORBID OBESITY

More trials for these conditions

Other studies related to the condition(s) this trial covers.